<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">r-n-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский неврологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian neurological journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2658-7947</issn><issn pub-type="epub">2686-7192</issn><publisher><publisher-name>МИА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2658-7947-2026-31-3-51-62</article-id><article-id custom-type="elpub" pub-id-type="custom">r-n-j-856</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЯ И КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL RESEARCHES AND CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Медико-организационная модель профилактики сердечно-сосудистых осложнений у пациентов с фибрилляцией предсердий на основе клинико-физиологической оценки факторов риска</article-title><trans-title-group xml:lang="en"><trans-title>Medical organizational model for prevention of cardiovascular complications in patients with atrial fi brillation based on clinical physiological assessment of risk factors</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3085-7729</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голощапов-Аксенов</surname><given-names>Р. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Goloshchapov-Aksenov</surname><given-names>R. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">goloschapovaksenovr@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2366-311X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фомина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fomina</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">fomina-av@rudn.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9134-7189</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рукодайный</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rukodaynyy</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">orukodaynyy@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6529-372X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кича</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kicha</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">d_kitcha@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7274-0276</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колединский</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Koledinsky</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">kard.gkb79@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7462-9691</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Багин</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bagin</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">03sabg@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-5011-0144</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Макарян</surname><given-names>Э. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Makaryan</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">emakaryan@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-7149-9114</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волков</surname><given-names>П. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Volkov</surname><given-names>P. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Московская область</p></bio><bio xml:lang="en"><p>Moscow region</p></bio><email xlink:type="simple">xirulk@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский университет дружбы народов имени Патриса Лумумбы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia named after Patrice Lumumba</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Медикал Он Груп-Одинцово</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical On Group-Odintsovo</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>31</day><month>08</month><year>2026</year></pub-date><volume>31</volume><issue>3</issue><fpage>51</fpage><lpage>62</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Голощапов-Аксенов Р.С., Фомина А.В., Рукодайный О.В., Кича Д.И., Колединский А.Г., Багин С.А., Макарян Э.А., Волков П.С., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Голощапов-Аксенов Р.С., Фомина А.В., Рукодайный О.В., Кича Д.И., Колединский А.Г., Багин С.А., Макарян Э.А., Волков П.С.</copyright-holder><copyright-holder xml:lang="en">Goloshchapov-Aksenov R.S., Fomina A.V., Rukodaynyy O.V., Kicha D.I., Koledinsky A.G., Bagin S.A., Makaryan E.A., Volkov P.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.r-n-j.com/jour/article/view/856">https://www.r-n-j.com/jour/article/view/856</self-uri><abstract><p>Введение. Совершенствование профилактики сердечно-сосудистых осложнений (ССО) является актуальной проблемой. Клинико-физиологическая аналитика (КФА) является доказательной основой выбора персонализированной модели профилактики ССО.Цель исследования. Разработать медико-организационную модель профилактики ССО на примере фибрилляции предсердий (ФП) на основе КФА факторов риска (ФР).Материал и методы. Выполнено многоцентровое исследование в период 2017–2026 гг. Объекты исследования — пациенты с ФП (n = 421), средний возраст 63 ± 4,2 лет. Основная группа (n = 303) — пациенты с пароксизмальной формой ФП в период вне пароксизма. Группа контроля (n = 118) — пациенты с персистирующей формой ФП после восстановления синусового ритма сердца: с применением электроимпульсной терапии — группа контроля №1 (n = 67) и термоабляции устьев легочных вен — группа контроля №2 (n = 51). Предмет исследования — распространенность ФР ССО, процессные компоненты медико-организационной модели профилактики ССО при ФП, медико-социальная эффективность модели профилактики ССО при ФП. Период наблюдения за пациентами 12 мес. Методы исследования: анализ литературы, статистический, клинико-физиологическая аналитика, систематизация, сравнительный анализ.Результаты. Распространенными ФР ССО при ФП (более 80% пациентов в группе), без достоверной разницы в группах, установлены артериальная гипертензия, нарушение ритма сердца по типу синусовой тахикардии и экстрасистолии, хроническая сердечная недостаточность (ХСН), дорсо- и цервикопатия. В основной группе по сравнению с контрольной было достоверно меньше пациентов с низкой физической активностью (9% и 74,6%, р = 0,001) и часто употребляющих алкоголь (27% и 47%, р = 0,01). Процессные компоненты медико-организационной модели профилактики ССО включают персонализированный подход на основе технологии клинического управления и применения искусственного интеллекта, клинико-физиологическую аналитику ФР ССО. Через 12 мес. наблюдения доля пациентов с возвратом ФП в основной группе составила 2%, группе контроля №1 — 5% и группе контроля №2 — 11%. Темп прироста приверженных пациентов амбулаторно-поликлинической помощи в среднем составил 389% без достоверной разницы между группами; инсульт, инфаркт миокарда, смерть и желудочно-кишечные кровотечения в группах не зафиксированы; доли пациентов в основной и контрольной группах с прогрессированием ХСН составили 3% и 13,56%, соответственно (р = 0,025).Заключение. Приверженность пациентов амбулаторно-поликлинической помощи, разработка и внедрение модели профилактики ССО при ФП на основе КФА ФР способствовали низкой частоте возврата ФП после успешного восстановления синусового ритма сердца, предупреждению прогрессирования ХСН и возникновению неблагоприятных конечных клинических сердечно-сосудистых исходов.</p></abstract><trans-abstract xml:lang="en"><p>Introduction. Improving the prevention of cardiovascular complications (CVC) is an actual problem. Clinical physiological analytics (CPA) provides an evidence basis for selecting a personalized model prevention ov CVC.Purpose: тo develop a medical organizational model for prevention of cardiovascular complications (CVC) in patients with atrial fibrillation (AF) based on the CPA of risk factors (RF).Material and methods. A multicenter research was in period 2017–2026. The research subjects — patients with AF (n = 421), average age of 63 ± 4.2 years. The main research group (n = 303) included patients with paroxysmal AF during periods between paroxysms. The control group (n = 118) included patients with persistent AF after restoration of sinus heart rhythm using: electrical impulse therapy — control group №1 (n = 67) and thermal ablation of the pulmonary vein orifices — control group №2 (n = 51). The research objectives were the prevalence of CVC RF, the process components of a medical organizational model for CVC prevention in patients with AF, and the medical social effectiveness of the model. The follow-up period of patients was 12 months. Research methods included literature review, statistical analysis, clinical physiological analysis, systematization and comparative analysis.Results. RF of CVC in patients with AF (more than 80% of patients in the group), with no significant differences between groups, included arterial hypertension, cardiac arrhythmia such as sinus tachycardia and extrasystole, chronic heart failure (CHF), and dorso- and cervicopathy. Compared to the control group, the main research group had significantly fewer patients with low physical activity (9% vs. 74.6%, p = 0.001) and frequent alcohol consumption (27% vs. 47%, p = 0.01). The process components of the medical organizational model for CVC prevention include a comprehensive patient-centered approach based on clinical management technology and artificial intelligence, clinical physiological analytics of the CVC RF. The proportion of patients with recurrent AF was 2% in the main group, 5% in control group №1, and 11% in control group №2. The increase in the proportion of adherent primary care patients over 12 months averaged 389%, with no significant difference between the groups. Stroke, myocardial infarction, death, or gastrointestinal bleeding were not identified in the all groups. The proportions of patients with CHF progression in the main and control groups after 12 months of follow-up were 3% and 13.56%, respectively (p = 0.025).Conclusion. Adherence of patients to primary care and cardiovascular prevention model based on the CFA FR contributed to a low rate of AF recurrence after successful restoration of sinus heart rhythm and progression of CHF, as well as the effective prevention of adverse clinical cardiovascular outcomes.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>клинико-физиологическая аналитика</kwd><kwd>сердечно-сосудистые осложнения</kwd><kwd>фибрилляция предсердий</kwd><kwd>первичная медико-санитарная помощь</kwd><kwd>приверженность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>clinical physiological analytics</kwd><kwd>cardiovascular complications</kwd><kwd>atrial fibrillation</kwd><kwd>primary care</kwd><kwd>adherence</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Вейбл ЭР. Будущее физиологии. Физиология человека. 1998;24(4):5.</mixed-citation><mixed-citation xml:lang="en">Weible ER. The future of physiology. Human Physiology. 1998;24(4):5 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ma Q, Zhu J, Zheng P, Zhang J, Xia X, Zhao Y. Global burden of atrial fi brillation/fl utter: Trends from 1990 to 2019 and projections until 2044. Heliyon. 2024;10:e24052. doi: 10.1016/J.HELIYON.2024.E24052</mixed-citation><mixed-citation xml:lang="en">Ma Q, Zhu J, Zheng P, Zhang J, Xia X, Zhao Y. Global burden of atrial fi brillation/fl utter: Trends from 1990 to 2019 and projections until 2044. Heliyon. 2024;10:e24052. doi: 10.1016/J.HELIYON.2024.E24052</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vinter N, Cordsen P, Johnsen S, Staerk L, Benjamin E, Frost L. Temporal trends in lifetime risks of atrial fi brillation and its complications between 2000 and 2022: Danish, nationwide, population-based cohort study. BMJ. 2024;385:e077209. doi: 10.1136/bmj-2023-077209</mixed-citation><mixed-citation xml:lang="en">Vinter N, Cordsen P, Johnsen S, Staerk L, Benjamin E, Frost L. Temporal trends in lifetime risks of atrial fi brillation and its complications between 2000 and 2022: Danish, nationwide, population-based cohort study. BMJ. 2024;385:e077209. doi: 10.1136/bmj-2023-077209</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kalarus Z, Mairesse G, Sokal A, Boriani G, Średniawa B, Casado-Arroyo R. Searching for atrial fi brillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper. EP Eur. 2023;25:185–198. doi: 10.1093/europace/euac144</mixed-citation><mixed-citation xml:lang="en">Kalarus Z, Mairesse G, Sokal A, Boriani G, Średniawa B, Casado-Arroyo R. Searching for atrial fi brillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper. EP Eur. 2023;25:185–198. doi: 10.1093/europace/euac144</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Муромцева ГА, Шальнова СА, Явелов ИС, Иевлев РВ, Максимов СА, Капустина АВ, Баланова ЮА, Евстифеева СЕ, Имаева АЭ, Яровая ЕБ, Драпкина ОМ. Популяционный портрет фибрилляции предсердий по данным ЭССЕ-РФ. Профилактическая медицина. 2025;28(11):7–13.</mixed-citation><mixed-citation xml:lang="en">Muromtseva GA, Shalnova SA, Yavelov IS, Ievlev RV, Maksimov SA, Kapustina AV, Balanova Yu.A., Evstifeeva SE, Imaeva AE, Yarovaya EB, Drapkina OM. Population portrait of atrial fi brillation according to ESSE-RF data. Preventive medicine. 2025;28(11):7–13 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Liu S, Tan Y, Huang Ц, Luo H, Pan В. Wu S. Cardiovascular safety of zoledronic acid in the treatment of primary osteoporosis: A meta-analysis and systematic review. Seminars in Arthritis and Rheumatism.2024;Vol.64,152304. doi: 10.1016/j.semarthrit.2023.152304</mixed-citation><mixed-citation xml:lang="en">Liu S, Tan Y, Huang Ц, Luo H, Pan В. Wu S. Cardiovascular safety of zoledronic acid in the treatment of primary osteoporosis: A meta-analysis and systematic review. Seminars in Arthritis and Rheumatism.2024;Vol.64,152304. doi: 10.1016/j.semarthrit.2023.152304</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hu Z, Ding L, Yao Y. Atrial fi brillation: mechanism and clinical management. Chin Med J. 2023;136:2668–2676. doi: 10.1097/CM9.0000000000002906</mixed-citation><mixed-citation xml:lang="en">Hu Z, Ding L, Yao Y. Atrial fi brillation: mechanism and clinical management. Chin Med J. 2023;136:2668–2676. doi: 10.1097/CM9.0000000000002906</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hu D, Barajas-Martinez H, Zhang Z, Duan H, Zhao Q, Bao M, Du Y, Burashnikov A, Monasky M, Pappone C, Huang C, Antzelevitch C, Jiang H. Advances in basic and translational research in atrial fi brillation. Philos Trans R Soc Lond B Biol Sci. 2023;19;378(1879):20220174. doi: 10.1098/rstb.2022.0174</mixed-citation><mixed-citation xml:lang="en">Hu D, Barajas-Martinez H, Zhang Z, Duan H, Zhao Q, Bao M, Du Y, Burashnikov A, Monasky M, Pappone C, Huang C, Antzelevitch C, Jiang H. Advances in basic and translational research in atrial fi brillation. Philos Trans R Soc Lond B Biol Sci. 2023;19;378(1879):20220174. doi: 10.1098/rstb.2022.0174</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Voskoboinik A, Kalman J, Anurica de Silva, Nicholls T, Costello B, Nanayakkara S, et al. Alcohol abstinence in drinkers with atrial fi brillation. N Engl J Med. 2020;382:20–28. doi: 10.1056/NEJMoa1817591</mixed-citation><mixed-citation xml:lang="en">Voskoboinik A, Kalman J, Anurica de Silva, Nicholls T, Costello B, Nanayakkara S, et al. Alcohol abstinence in drinkers with atrial fi brillation. N Engl J Med. 2020;382:20–28. doi: 10.1056/NEJMoa1817591</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Garnvik L, Malmo V, Janszky I, Ellekjær H, Wislоff U, Loennechen J, Nes B. Physical activity, cardiorespiratory fi tness, and cardiovascular outcomes in individuals with atrial fi brillation: the HUNT study. Eur Heart J. 2020;41(15):1467–1475. doi: 10.1093/eurheartj/ehaa032</mixed-citation><mixed-citation xml:lang="en">Garnvik L, Malmo V, Janszky I, Ellekjær H, Wislоff U, Loennechen J, Nes B. Physical activity, cardiorespiratory fi tness, and cardiovascular outcomes in individuals with atrial fi brillation: the HUNT study. Eur Heart J. 2020;41(15):1467–1475. doi: 10.1093/eurheartj/ehaa032</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tatangelo M, Rebecchi M, Sgueglia M, Colella A, Crescenzi C, Panattoni G. The complex but fascinating relationship between sport and atrial fi brillation: from pathophysiology to the clinical scenario. J Cardiovasc Dev Dis. 2023;10: 255. doi: 10.3390/jcdd10060255</mixed-citation><mixed-citation xml:lang="en">Tatangelo M, Rebecchi M, Sgueglia M, Colella A, Crescenzi C, Panattoni G. The complex but fascinating relationship between sport and atrial fi brillation: from pathophysiology to the clinical scenario. J Cardiovasc Dev Dis. 2023;10: 255. doi: 10.3390/jcdd10060255</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wingerter R, Steiger N, Burrows A, Estes N. Impact of Lifestyle Modifi cation on Atrial Fibrillation. Am. J. Cardiol. 2020;125:289–297.</mixed-citation><mixed-citation xml:lang="en">Wingerter R, Steiger N, Burrows A, Estes N. Impact of Lifestyle Modifi cation on Atrial Fibrillation. Am. J. Cardiol. 2020;125:289–297.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Soliman E, Rahman A, Zhang Z, Rodriguez C, Chang T, Bates J. Eff ect of intensive blood pressure lowering on the risk of atrial fi brillation. Hypertension. 2020;75:1491–1496. doi: 10.1161/HYPERTENSIONAHA.120.14766</mixed-citation><mixed-citation xml:lang="en">Soliman E, Rahman A, Zhang Z, Rodriguez C, Chang T, Bates J. Eff ect of intensive blood pressure lowering on the risk of atrial fi brillation. Hypertension. 2020;75:1491–1496. doi: 10.1161/HYPERTENSIONAHA.120.14766</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Wang A, Green J, Halperin J, SrPiccini J. Atrial fi brillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol. 2019;74:1107–1115. doi: 10.1016/j.jacc.2019.07.020</mixed-citation><mixed-citation xml:lang="en">Wang A, Green J, Halperin J, SrPiccini J. Atrial fi brillation and diabetes mellitus: JACC review topic of the week. J Am Coll Cardiol. 2019;74:1107–1115. doi: 10.1016/j.jacc.2019.07.020</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Гордон ИБ, Гордон АИ. Церебральные и периферические расстройства в клинической кардиологии. М: Медицина. 1994. 160 с.</mixed-citation><mixed-citation xml:lang="en">Gordon IB, Gordon AI. Cerebral and peripheral disorders in clinical cardiology. Moscow: Meditsina. 1994. 160 p. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Голощапов-Аксенов РС, Багин СА, Колединский АГ, Рукодайный ОВ. Практикум по клиническому управлению = Practicum of clinical management. Москва: РУДН, 2025. 95 с.</mixed-citation><mixed-citation xml:lang="en">Goloshchapov-Aksenov RS, Bagin SA, Koledinsky AG, Rukodaynyy OV. Practicum of clinical management. Moscow: RUDN University, 2025. 95 p. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Голощапов-Аксенов РС, Колединский АГ, Фомина АВ, Кича ДИ, Рукодайный ОВ, Багин СА. Клинико-физиологическая аналитика в управлении стабильным течением гипертонической болезни (на примере пожилых пациентов). В книге: Vocal function: a dialogue between specialists (ISCPP2025). Тезисы III конгресса Международного общества клинической физиологии и патологии. Москва — Херцег-Нови — Каракас, 2025:115–117.</mixed-citation><mixed-citation xml:lang="en">Goloshchapov-Aksenov RS, Koledinsky AG, Fomina AV, Kicha DI, Rukodaynyy OV, Bagin SA. Clinical and physiological analytics in the management of stable hypertension (using elderly patients as an example). In: Vocal function: a dialogue between specialists (ISCPP2025). Abstracts of the III Congress of the International Society of Clinical Physiology and Pathology. Moscow — Herceg Novi — Caracas, 2025. 115–117. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Национальный стандарт Российской Федерации ГОСТР 59921.9-2022 «Системы искусственного интеллекта в клинической медицине. Алгоритмы анализа данных в клинической физиологии». Утвержден и введен в действие Приказом Федерального агентства по техническому регулированию и метрологии от 18 октября 2022 г. № 1144-ст. https://base.garant.ru/406583621/</mixed-citation><mixed-citation xml:lang="en">National Standard of the Russian Federation GOST R 59921.9- 2022 «Artifi cial Intelligence Systems in Clinical Medicine. Data Analysis Algorithms in Clinical Physiology.” Approved and put into eff ect by Order of the Federal Agency for Technical Regulation and Metrology dated October 18, 2022, No.1144-st. https://base.garant.ru/406583621/ (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральный закон от 29 июня 2015 г. № 162-ФЗ «О стандартизации в Российской Федерации». https://www.consultant.ru/document/cons_doc_LAW_181810/</mixed-citation><mixed-citation xml:lang="en">Federal Law dated June 29, 2015, No. 162-FZ “On Standardization in the Russian Federation.” https://www.consultant.ru/document/cons_doc_LAW_181810/ (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации «Фибрилляция и трепетание предсердий у взрослых — 2020-2021-2022 (10.06.2021)». https://disuria.ru/_ld/11/1114_kr20I48MZ.pdf</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines “Atrial Fibrillation and Flutter in Adults — 2020-2021-2022 (June 10, 2021)”. https://disuria.ru/_ld/11/1114_kr20I48MZ.pdf (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации «Фибрилляция предсердий». 2025 г. https://old.scardio.ru/content/Guidelines/2025/КР%20Фибрилляция_трепетание_предсердий%2002.09.25_рамка.pdf</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines “Atrial Fibrillation”. 2025. https://old.scardio.ru/content/Guidelines/2025/КР%20Фибрилляция_трепетание_предсердий%2002.09.25_рамка.pdf (In Russian).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
